←back to thread

331 points breve | 1 comments | | HN request time: 0s | source
Show context
quotemstr ◴[] No.45027889[source]
Broad-based inflammation delivered by lipid nanoparticle chock full of mRNA: what could possibly go wrong? I'll stick with monoclonal antibodies, thanks.

Oh, and here's what the ISG15 deficiency (the condition these mRNAs are there to simulate) does:

> Patients present...with infectious, neurologic or dermatologic features. Basal ganglia calcification is observed in all patients... The basal ganglia calcifications may cause epileptic seizures... The IFN-I inflammation may also manifest early in life as ulcerative skin lesions in the armpit, groin and neck regions. Finally, ISG15-deficiency leads to mendelian susceptibility to mycobacterial disease... [t]hese infections present as fistulizing lymphadenopathies and respiratory symptoms following BCG vaccination.

Yeah, about those antiviral superpowers...

replies(2): >>45028338 #>>45029463 #
mapontosevenths ◴[] No.45028338[source]
What's wrong with mRNA, or lipid nanoparticles?
replies(1): >>45028456 #
1. mapontosevenths ◴[] No.45028456[source]
For the record, here are the primary researchers qualifications: https://www.pediatrics.columbia.edu/profile/dusan-bogunovic-...

His reputably published, peer reviewed, work can be found here: https://www.science.org/doi/10.1126/scitranslmed.adx5758